- Home
- PPBT vs IBO Comparison
PPBT vs IBO Comparison
Compare PPBT & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- IBO
- Stock Information
- Founded
- PPBT 2010
- IBO 2018
- Country
- PPBT Israel
- IBO United States
- Employees
- PPBT N/A
- IBO N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- IBO
- Sector
- PPBT Health Care
- IBO
- Exchange
- PPBT Nasdaq
- IBO NYSE
- Market Cap
- PPBT 6.3M
- IBO 5.8M
- IPO Year
- PPBT N/A
- IBO 2024
- Fundamental
- Price
- PPBT $2.34
- IBO $0.76
- Analyst Decision
- PPBT Strong Buy
- IBO
- Analyst Count
- PPBT 1
- IBO 0
- Target Price
- PPBT $33.00
- IBO N/A
- AVG Volume (30 Days)
- PPBT 29.4K
- IBO 23.2M
- Earning Date
- PPBT 08-15-2025
- IBO 08-23-2025
- Dividend Yield
- PPBT N/A
- IBO N/A
- EPS Growth
- PPBT N/A
- IBO N/A
- EPS
- PPBT N/A
- IBO N/A
- Revenue
- PPBT N/A
- IBO N/A
- Revenue This Year
- PPBT N/A
- IBO N/A
- Revenue Next Year
- PPBT N/A
- IBO N/A
- P/E Ratio
- PPBT N/A
- IBO N/A
- Revenue Growth
- PPBT N/A
- IBO N/A
- 52 Week Low
- PPBT $2.00
- IBO $0.36
- 52 Week High
- PPBT $13.95
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- PPBT 41.27
- IBO N/A
- Support Level
- PPBT $2.30
- IBO N/A
- Resistance Level
- PPBT $2.45
- IBO N/A
- Average True Range (ATR)
- PPBT 0.14
- IBO 0.00
- MACD
- PPBT -0.03
- IBO 0.00
- Stochastic Oscillator
- PPBT 16.58
- IBO 0.00
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.